Contents

Current Molecular Pharmacology, Volume 3 - Number 3

Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

, 3(3): 98 - 122

Ota Fuchs


DOI: 10.2174/1874467211003030098




Concanavalin A, from an Old Protein to Novel Candidate Anti-Neoplastic Drug

, 3(3): 123 - 128

Chun-Yang Li, Huai-Long Xu, Bo Liu and Jin-Ku Bao


DOI: 10.2174/1874467211003030123




The Enigmatic Drug Binding Site for Sodium Channel Inhibitors

, 3(3): 129 - 144

Arpad Mike and Peter Lukacs


DOI: 10.2174/1874467211003030129




Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety

, 3(3): 145 - 152

Benjamin Ngo, Christopher P. Farrell, Maura Barr, Kevin Wolov, Robert Bailey, James M. Mullin and James J. Thornton


DOI: 10.2174/1874467211003030145




Biological Activities of Natural and Engineered Cyclotides, a Novel Molecular Scaffold for Peptide-Based Therapeutics

, 3(3): 153 - 163

Angie E. Garcia and Julio A. Camarero


DOI: 10.2174/1874467211003030153




Drug Screening for Huntingtons Disease and other Neurodegenerative Disorders

, 3(3): 164 - 173

Hemant Varma


DOI: 10.2174/1874467211003030164




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science